Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103)

Diabetes Technology and Therapeutics

Volumn 13, Issue 4, 2011, Pages 477-482

  Surendar, Jayagopi ^a   Mohan, Viswanathan ^a,b   Rao, Maradana Muralidhara ^a   Babu, Subash ^c   Aravindhan, Vivekanandhan ^a,d  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b Dr Mohan's Diabetes Specialities Centre   (India)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d ANNA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GAMMA INTERFERON; GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INDIAN; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TH1 CELL; TH2 CELL; UPREGULATION;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; CHOLESTEROL; CYTOKINES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIA; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; TH1 CELLS; TH2 CELLS; TRIGLYCERIDES; UP-REGULATION; URBAN POPULATION;

EID: 79953173984     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0178     Document Type: Article

References (38)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752. Erratum in: Circulation 2005;112:e297 and 2005;112:e298.
2. Hu FB: Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids 2003;38:103-108. (Pubitemid 36457717)
3. Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H: The metabolic syndrome and dyslipidemiaamong Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometab Syndr 2007;2:267-275.
4. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C: Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-230. (Pubitemid 46805444)
5. Esposito K, Giugliano D: The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004;14:228-232. (Pubitemid 39611863)
6. Giugliano D, Ceriello A, Esposito K: The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006;48:677-685. (Pubitemid 44175717)
7. Andreassi MG: Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Mutat Res 2009;667:35-43.
8. Ridker PM, Wilson PW, Grundy SM: Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109:2818-2825. (Pubitemid 38780294)
9. Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V: Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance-the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 2006;55:1232-1238. (Pubitemid 44215943)
10. Gokulakrishnan K, Deepa R, Mohan V: Association of high sensitivity C-reactive protein (hsCRP) and tumour necrosis factor-alpha (TNF-alpha) with carotid intimal medial thickness in subjects with different grades of glucose intolerance- the Chennai Urban Rural Epidemiology Study (CURES-31). Clin Biochem 2008;41:480-485.
11. Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C, Hu FB: A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 2005;28:1376-1382. (Pubitemid 40756700)
12. Kressel G, Trunz B, Bub A, Hülsmann O, Wolters M, Lichtinghagen R, Stichtenoth DO, Hahn A: Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis 2009;202:263-271.
13. Brown DM: Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell Immunol 2010;262:89-95.
14. Veldhoen M: The role of T helper subsets in autoimmunity and allergy. Curr Opin Immunol 2009;21:606-611.
15. Pacifico L, Di Renzo L, Anania C, Osborn JF, Ippoliti F, Schiavo E, Chiesa C: Increased T-helper interferon-gammasecreting cells in obese children. Eur J Endocrinol 2006;154:691-697. (Pubitemid 43810855)
16. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, Hauner H, Blüher M, Unger T, Wolf AM, Knippschild U, Hombach V, Marx N: T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesitymediated insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1304-1310.
17. Wegner M, Winiarska H, Bobkiewicz-Koz1owska T, Dworacka M: IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine 2008;42:312-316.
18. Waite KJ, Floyd ZE, Arbour-Reily P, Stephens JM: Interferon- gamma-induced regulation of peroxisome proliferatoractivated receptor gamma and STATs in adipocytes. J Biol Chem 2001;276:7062-7068.
19. Surendar J, Aravindhan V, Rao MM, Ganesan A, Mohan V: Decreased serum interleukin-17 and increased transforming growth factor-beta levels in subjects with metabolic syndrome (Chennai Urban Rural Epidemiology Study-95). Metabolism 2010 Jul 27 [Epub ahead of print].
20. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, Mohan V: The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003;51: 863-870. (Pubitemid 41279865)
21. Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V: Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007;30:2019-2024. (Pubitemid 47219412)
22. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V: Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46:2328-2333. (Pubitemid 43119476)
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
24. World Health Organization, International Association for the Study of Obesity and International Obesity Task Force: The Asia Pacific Perspective: Redefining Obesity and Its Treatment. Sydney: Health Communications Australia Pty Ltd., 2000:17-21.
25. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006;444:860-867. (Pubitemid 46024993)
26. Shoelson SE, Herrero L, Naaz A: Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169-2180.
27. Syrenicz A, Garanty-Bogacka B, Syrenicz M, Gebala A, Walczak M: Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. Neuro Endocrinol Lett 2006;27:453-458. (Pubitemid 46043601)
28. Ben-Dor I, Hasdai D, Behar S, Zahger D, Leor J, Hammerman H, Sandach A, Hod H, Gottlieb S; Working Group on Intensive Cardiac Care, Israel Heart Society: Prognostic implications of increased cardiac biomarkers and ST segment depression in non-ST elevation acute coronary syndromes: lessons from the Acute Coronary Syndrome Israeli Survey (ACSIS) 2002. Heart 2006;92:547-548.
29. Cizmecioglu FM, Etiler N, Ergen A, Gormus U, Keser A, Hekim N, Hamzaoglu O, Hatun S: Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence. Exp Clin Endocrinol Diabetes 2009;117:622-627.
30. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M, Schwanke CH, Bodanese LC: Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. J Clin Endocrinol Metab 95:586-591.
31. Ingelsson E, Hulthe J, Lind L: Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest 2008;38:502-509. (Pubitemid 351832033)
32. Daniel J, Mandar T, Lin S: Parasite loads are higher in the tropics: temperate to tropical variation in a single host-parasite system. Ecography 2008;31:538-544.
33. Maartens G, Beyers N: Tuberculosis in the tropics. Clin Chest Med 2002;23:341-350. (Pubitemid 34651329)
34. Kim CX, Bailey KR, Klee GG, Ellington AA, Liu G, Mosley TH Jr, Rehman H, Kullo IJ: Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic Proteomic Markers of Arteriosclerosis Study. PLoS One 2010;5:e9065.
35. Gutierrez DA, Puglisi MJ, Hasty AH: Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Curr Diabetes Rep 2009;9:26-32.
36. McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM, Smyth EM, Reilly MP: Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem 2009;284:31936-31944.
37. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE l: The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999;17:701-738. (Pubitemid 29241138)
38. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HM: Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009;15:921-929.